Alpine Investors Announces Partnership with Leading Revenue Cycle Management Provider, Medusind
Alpine Investors, a people-driven private equity firm, announced that it has made an investment in Medusind, a leading provider of revenue cycle management services to the healthcare industry. Jose Rivero, an Alpine CEO-in-Residence and part of the firm’s PeopleFirst program, has assumed the role of CEO of Medusind. Terms of the private transaction were not disclosed.
Artificial Intelligence News : Merlin AI, the Evolution of ChatGPT is Now a Freestanding Mobile App
Founded in 2002, Medusind provides deep expertise and powerful revenue cycle management solutions to dental, anesthesia, pathology, emergency, surgery, radiology, and other specialties. Medusind’s proprietary technology platforms allows its customers to deliver superior outcomes to healthcare provider practices. For over two decades, Medusind has seen dynamic growth across markets with its expanded services, strategic acquisitions and an incomparable team of experts. As of 2022, Medusind has processed over $2b in claims, served over 30k physicians, and supported over 30+ EMR platforms. Amongst Medusind’s many differentiators are its 120+ person technology team with 85+ developers and world-class service with a 96% clean claims rate.
“On behalf of everyone at Alpine, we are excited to collaborate with Jose and the Medusind management team to continue to advance its leadership position as one of the top revenue cycle management companies in the country,” said Graham Weaver, CEO and Founding Partner at Alpine Investors. “We believe we are the ideal partners to help Medusind accelerate its growth, continue to provide an exceptional level of customer service, and improve the efficiency and profitability for its clients.”
Artificial Intelligence Technology : How Artificial Intelligence Will Help Facilitate the Hybrid Working Environment
“I couldn’t be more thrilled and honored to join the Medusind team,” said Jose Rivero, CEO of Medusind. “With the collective experience of the Medusind team, we will maintain our current strategy and commitment to delivering superior business results and world-class customer service to our clients. At the same time, we will leverage Alpine’s healthcare and technology experience to accelerate our investments in analytics, AI, new services, strategic acquisitions, and new specialties.”
AI in Advertising : AI in Advertising and Marketing – Hype, Disillusionment, Back to Hype Again?
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.